Penn Medicine is conducting medical studies to develop new diagnostic and clinical treatments to improve current standards of care.
Search By Keywords
Example: Diabetes, Cardiology, John Smith
Browse by Disease or Condition
Recently Added/Updated Trials
-
EXPLORATORY PILOT STUDY TO DISCOVER GENES THAT RESTORE THE MOLECULAR CIRCADIAN RHYTHM
Read moreThe main purpose of this study is to see if blood serum collected from healthy young volunteers has a different effect on biorhythms measured in ... -
Cancer Pain Self-Management Study
You are being asked to take part in a research study about medications used for cancer pain. This research is not a form of treatment ...Read more -
Guided Behavioral Approaches for Insomnia in Older Adults (TapToSleep)
Do you often struggle to fall asleep at night? The University of Pennsylvania, in partnership with Advanced Medical Electronics, have developed a low-risk, non-pharmacologic intervention ... Read more
-
Phase 1 Open-Label Study to Determine the Safety and Tolerability of AVID200, a Transforming Growth Factor B Inhibitor, in Diffuse Cutaneous Systemic Sclerosis
Read moreThis study is being done to learn more about the safety of the study drug, AVID200, and to find out more about the effects of ... -
Abatacept (CTLA4-Ig) for the Treatment of Relapsing, Non-Severe, Granulomatosis with Polyangiitis (Wegener’s) (ABROGATE)
This is a clinical trial to determine the effectiveness and safety of the investigational drug, abatacept, in treating patients with granulomatosis with polyangiitis (GPA). GPA ... Read more
-
VCRC Longitudinal Protocol for Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss): 5506
The study is being done to learn more about Eosinophilic Granulomatosis with Polyangiitis (EGPA), also known as a Churg-Strauss, a disease that affects the medium ...Read more -
Randomized, Double-blind, Placebo-controlled, Phase II Study to Investigate Safety and Efficacy of 2 Different Dose Regimens of IFX-1 as Add-on to Standard of Care for GPA and MPA
Read moreThis clinical research study will look at an investigational study drug called IFX-1. It is being investigated for the first time in people who have ... -
Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Sarilumab in Giant Cell Arteritis
Read moreThe main purpose of this study is to understand how well giant cell arteritis (also known as temporal arteritis; GCA) responds to an investigational drug ...
